Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Safety and Efficacy of Enoxaparin and Hydroxychloroquine in COVID-19

  • Authors : Raghda R.S. Hussein, Assistant Professor of Clinical Pharmacy

  • Source: Evaluation of Safety and Efficacy of Monotherapy Versus Polytherapy of Enoxaparin and Hydroxychloroquine for the Treatment of Covid-19

Record details

×
Report

The Danish Pre-HCQ COVID Dialysis Study

  • Authors : Nicholas Carlson, MD PhD

  • Source: The Danish Pre-HCQ Dialysis Study: Hydroxychloroquine for Prevention of COVID19 in Dialysis-treated Patients With End-stage Renal Disease - A Multicenter Parallel-group

Record details

×
Report

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) (PLATCOV)

  • Source: Finding Treatments for COVID-19: A Phase 2 Multi-centre Adaptive Platform Trial to Assess Antiviral Pharmacodynamics in Early Symptomatic

Record details

×
Report

Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 (PEP-CQ)

  • Authors : Deba Prasad Dhibar, Assistant Professor

  • Source: Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 in Asymptomatic Individual at Risk for

Record details

×
Report

Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19 (DOXYCOV)

  • Authors : Sobngwi Eugene, Medical Director

  • Source: Open-label, Randomized Trial of the Safety and Efficacy of Doxycycline and Rivaroxaban Therapy Versus National Standard Therapy in Ambulatory Patients With Mild Symptomatic

Record details

×
Report

Ivermectin for Severe COVID-19 Management

  • Source: Guan WJ, NZY, Hu Y, Lng WH, Ou CQ, He JX, L L, Shan H, LeCL, HuDSC, Du B, LLJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xng J, LSY, Wang JL, Lng ZJ, Peng YX, WeL, L Y, Hu YH, Peng P, Wang

Record details

×
Report

Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients

  • Source: A Multi Centre, Randomised, Controlled, Open-Label Phase 2/3 Study to Evaluate The Efficacy, Tolerability and Safety of Metabolic Cofactor Supplementation and

Record details

×
Report

Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) (COALITION-V)

  • Source: Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in

Record details

×
Report

Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19

  • Authors : Mohammad Sadegh Bagheri Baghdasht, Principal Investigator

  • Source: Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 Disease in

Record details

×
Report

Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic

  • Authors : Dr Shiva Shankar Bugude, Assistant Professor

  • Source: Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic: An Observational Study

Record details

×
  • 1-10 of  170 results for ""COVID-19""